Advancing Efforts in Disease Interception - a podcast by Scientific American

from 2020-02-27T11:45

:: ::

Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.

Further episodes of Science Talk

Further podcasts by Scientific American

Website of Scientific American